Aisling Capital Management as of March 31, 2019
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 12 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eidos Therapeutics | 20.1 | $26M | 1.1M | 23.45 | |
| Avrobio Ord (AVRO) | 13.6 | $18M | 812k | 22.05 | |
| Obseva Sa | 13.5 | $18M | 1.4M | 12.79 | |
| Biohaven Pharmaceutical Holding | 10.8 | $14M | 275k | 51.47 | |
| Marker Therapeutics Ord | 10.1 | $13M | 2.0M | 6.60 | |
| Aeglea Biotherapeutics | 7.5 | $9.8M | 1.2M | 8.05 | |
| Sunesis Pharmaceuticals Inc Ne | 7.1 | $9.3M | 7.6M | 1.22 | |
| Zosano Pharma Corp | 5.8 | $7.6M | 1.6M | 4.77 | |
| Nabriva Therapeutics | 3.4 | $4.4M | 1.8M | 2.44 | |
| Arcus Biosciences Incorporated (RCUS) | 3.2 | $4.2M | 333k | 12.49 | |
| Aclaris Therapeutics (ACRS) | 2.9 | $3.8M | 635k | 5.99 | |
| Verona Pharma Plc ads (VRNA) | 2.2 | $2.9M | 444k | 6.50 |
